biotech · WHIM Syndrome · Neutropenias · XFOR
X4 Pharmaceuticals
X4 Pharmaceuticals, Inc
X4 Pharmaceuticals clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
61 N Beacon St, Boston, Massachusetts 02134, US HQ
2014 Founded
81 Employees
Public company Type
XFOR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 61 N Beacon St, Boston, Massachusetts 02134, US
- Founded
- 2014
- Employees
- 81
- Programs
- 11
- Drugs
- 6
- Patents
- 16
X4 Pharmaceuticals projects
2 ClinicalTrials.gov programs sponsored by X4 Pharmaceuticals.
X4 Pharmaceuticals has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does X4 Pharmaceuticals have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.